Home » Topics » BioWorld Science

BioWorld Science
RSS

New prostate cancer treatment strategy may overcome resistance

Dec. 12, 2019

Synthesis and in vitro characterization of new analogues of manogepix against Cryptococcus spp.

Dec. 12, 2019

Acetyl CoA and metabolic health

Dec. 12, 2019

EicOsis initiates phase I trial of sEH inhibitor EC-5026 for pain

Dec. 11, 2019

Iterum reports topline data from phase III trial of sulopenem in cIAI

Dec. 11, 2019

hSTING agonists described in Incyte patent

Dec. 11, 2019

University of Texas System identifies KRAS-targeting compounds

Dec. 11, 2019

Alligator initiates first-in-human study of 4-1BB antibody ATOR-1017

Dec. 11, 2019

VenatoRx Pharmaceuticals patent details bacterial PBP3 inhibitors

Dec. 11, 2019

Primmune Therapeutics discloses new TLR7 agonists

Dec. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...